Several studies report its protective effect against AD pathology and the mitochondrial biogenesis by promoting the upregulation of the PGC1α gene through the regulation of a novel signaling pathway called HIF1an-AMPK-PGC1α (Islam et al., 2024; Kumar et al., 2021). This evidence concerns the gene PPARGC1A and Alzheimer disease.